RESEARCH-USE BIOSIMILAR ANTIBODY
Nirsevimab
Monoclonal antibody · IgG1
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV). Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections.
TARGETRSV
YMonoclonal antibody
CATALOGSC-BS-331
CATALOG NUMBERSC-BS-331
MOLECULAR WEIGHTApprox. 146.31 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Nirsevimab (MEDI8897) is a recombinant monoclonal antibody against human respiratory syncytial virus (RSV). Nirsevimab has neutralizing activity against RSV A and RSV B viruses, with IC50 values of 5.42 ng/mL and 9.71 ng/mL, respectively. Nirsevimab can be used for research on respiratory infections.
Nirsevimab is a recombinant research-use antibody directed against RSV.